Best hospitals for Oncology: A 2026 international ranking analysis

How oncology hospital rankings should be interpreted

The 2026 Newsweek and Statista World’s Best Specialized Hospitals oncology ranking places Memorial Sloan Kettering Cancer Center in New York City first, followed by MD Anderson Cancer Center in Houston and Samsung Medical Center in Seoul. The list includes 300 oncology hospitals worldwide and represents an international comparison rather than a diagnosis-specific treatment recommendation. 1

Rankings measure different aspects of hospital performance, so results can vary by methodology. Newsweek’s specialized-hospital assessment uses peer hospital recommendations, professional accreditations, and patient-reported outcomes, while U.S. News evaluates factors including outcomes, patient experience, nursing, technology, expert opinion, and other clinical measures. 2

Top 10 hospitals in the 2026 global oncology ranking

The following institutions occupy the first 10 positions in the Newsweek oncology table. The geographic distribution includes four hospitals in the United States, three in South Korea, and one each in France, the United Kingdom, and Canada. The ranking identifies broad institutional standing, but it does not establish that one hospital is the most appropriate choice for every cancer type or patient circumstance. 1

Other hospitals in the broader Newsweek list include Dana-Farber Brigham Cancer Center, Massachusetts General Hospital, Cleveland Clinic, Institut Curie, The Christie, Peter MacCallum Cancer Centre, Charité, National Cancer Center Hospital in Tokyo, and Cancer Institute Hospital of JFCR. Their inclusion illustrates that leading oncology capacity is distributed across multiple health systems and regions. 1

Leading U.S. cancer centers and differing results

MD Anderson was named the nation’s number-one hospital for cancer care in the 2026-2027 U.S. News Best Hospitals survey, marking its 12th consecutive year at the top of that U.S. cancer-care ranking. The institution also received national rankings in urology and gastroenterology, plus high-performing ratings for several procedures and conditions, including colon cancer surgery and lung cancer surgery. 3

U.S. News placed Memorial Sloan Kettering second nationally for cancer care in the same period, while Healio reported that Dana-Farber Brigham, Mayo Clinic Rochester, Massachusetts General Hospital, Johns Hopkins, and several other institutions were also in the national top group. These results differ from Newsweek’s global oncology ranking, where MSK placed first and MD Anderson second, demonstrating that rankings should be read within their stated scope. 4

Clinical focus, research, and trials

Memorial Sloan Kettering describes disease-specific cancer services, personalized care, clinical trials, and laboratory discoveries that inform new treatments. Mayo Clinic’s cancer programs combine multidisciplinary diagnosis and treatment with specialized services for rare and complex cancers and access to cancer clinical trials. These features can be particularly relevant when a case requires several specialties or investigational options. 5

Research credentials also vary by institution. The National Cancer Institute’s comprehensive designation reflects scientific leadership, research programs, training, and the capacity to translate discoveries into improved care. UC Davis reported renewal of its comprehensive designation together with an approximately 18 million dollar, five-year grant, and described the designation as applying to an elite group of 58 comprehensive cancer centers in the United States. 9

Services and credentials beyond global rank

Johns Hopkins’ Sidney Kimmel Comprehensive Cancer Center provides multidisciplinary oncology services and participates in federally supported cancer research. Cleveland Clinic’s Taussig Cancer Institute covers medical, surgical, radiation, hematologic, and precision oncology. UCSF’s Helen Diller Family Comprehensive Cancer Center integrates treatment, prevention, basic research, and clinical research. These categories can matter more than overall rank when care must be matched to a particular disease or therapy. 10

Institutional designation is useful but is not a substitute for evaluating the specific program. Montefiore Einstein identifies itself as an NCI-designated comprehensive cancer center, treats more than 400 cancer types, and reports more than 500 active clinical research studies. Stephenson Cancer Center is Oklahoma’s only NCI-designated cancer center and reports more than 250 ongoing biomedical research projects. 6 8

Practical constraints when comparing hospitals

Patients comparing oncology hospitals may assess disease-specific expertise, relevant outcomes, clinical-trial eligibility, accreditation, insurance coverage, travel requirements, and second-opinion services. Clinical-trial participation is governed by protocol requirements, diagnosis, prior treatment, health status, and other eligibility criteria, so the presence of a trial does not mean that every patient can enroll. A hospital’s overall position therefore cannot predict an individual treatment result. 10

Travel and continuity of care can create additional friction, especially when treatment involves repeated visits, supportive services, rehabilitation, or monitoring near the patient’s home. Stephenson reports locations across Oklahoma and nearly 200 clinical trials, while UF Health Shands reported a number 35 U.S. News cancer ranking and nearly 200 clinical trials through its cancer institute. Such figures describe institutional capacity, not guaranteed access or suitability. 7 8

What the rankings do not establish

A hospital ranking does not independently establish that a center offers superior care for every tumor type, stage, treatment approach, age group, or comorbidity. It also does not replace review of physician expertise, multidisciplinary planning, pathology review, treatment risks, expected follow-up, or communication between specialists. Rankings may be useful for identifying institutions with broad expertise, but clinical decisions require individualized medical assessment. 1

Regulatory and quality oversight should be considered alongside reputation. NCI designation involves rigorous review of research, clinical care, prevention, and education, while professional accreditations and patient-reported outcomes form part of Newsweek’s methodology. Even highly regarded hospitals face capacity limits, referral requirements, insurance rules, geographic barriers, and possible waiting periods. Those realities should be examined before interpreting a ranking as a practical care pathway. 9 1

Sources

1. Newsweek and Statista, World’s Best Specialized Hospitals 2026, Oncology
2. Oncology News Central, Annual Oncology Hospital Rankings Released
3. UT MD Anderson Cancer Center, 2026-2027 cancer-care ranking release
4. Healio, UT MD Anderson named nation’s best cancer hospital
5. Memorial Sloan Kettering Cancer Center
6. Montefiore Einstein Comprehensive Cancer Center
7. UF Health Cancer Institute
8. OU Health Stephenson Cancer Center
9. UC Davis Comprehensive Cancer Center
10. National Cancer Institute, U.S. News, Johns Hopkins, Cleveland Clinic, and UCSF cancer-center information